1. At a Glance – Protection with Valuation Anxiety
Cupid Ltd is no longer just India’s most awkward dinner-table stock. It has become one of the most explosive smallcap reratings in recent market history. With a market cap of ₹10,494 crore, a stock price of ₹390, and a 451% return in one year, Cupid has gone from “WHO-approved niche exporter” to “Instagram finfluencer favourite”.
Q3 FY26 was the company’s best quarter ever:
- Revenue: ₹104 Cr
- PAT: ₹32.9 Cr
- EBITDA margin: ~43%
- QoQ profit growth: +197%
- 3-month return: 67%
Sounds dreamy, right? But here’s the twist: the stock trades at 126x P/E, 27.5x book value, and EV/EBITDA of ~87x. That’s not protection, that’s exposure.
Is Cupid becoming a global sexual wellness FMCG giant, or has the stock already priced in every bedroom fantasy for the next decade? Let’s unzip the numbers.
2. Introduction – From NGO Supplier to Market Darling
Cupid was founded in 1993 and quietly built a global niche supplying male and female condoms to WHO, UNFPA, and governments across 100+ countries. For years, it was boring, profitable, and ignored.
Then three things happened:
- New management (Halwasiya family) entered in Oct 2023.
- Margins exploded post FY24 due to scale, pricing, and operating leverage.
- The market discovered that Cupid is not a sin stock – it’s a global public health exporter with FMCG optionality.
Suddenly, every quarterly result started looking like a startup demo day:
- Triple-digit growth
- Margin expansion
- Bonus issues
- Capacity expansion
- Saudi Arabia factory
- Brazil orders
- IVD kits
- Deodorants
- And now… fashion retail investments (yes, really)
Cupid is no longer subtle. It’s
